Loading...

PTIX PROTAGENIC THERAPEUTICS INC Company Mergers 8-K Filing

PRTG

PTX

PROTAGENIC THERAPEUTICS INC

(PTIX)

2025 8-K

Delisting Notification

Director Resignation

Legal Action Filed

Acquisition Update

Company Acquisition

Accounting Changes

Restructuring Plan

Rights Offerings

Warrant Exercises

Warrant Exchange

Asset Acquisitions

Stock Split Approval

Stock Option Repricing

Annual Meeting Results

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Filing with Quantitative Data

Quantitative Data

Annual Meeting Results

Quantitative Data

Reverse Stock Split

External Links:

On July 30, 2025, Protagenic Therapeutics, Inc. announced the grant of a new patent in Japan for its modified stilbenoid program drug candidates. This patent expands their intellectual property portfolio in a key market.

AI Assistant

PROTAGENIC THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.